Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Seeing Pfizer's share price fall nearly 60% from its peak wasn't so fun. Have I been tempted to sell during this major decline? Nope. Instead, I'm buying this beaten-down, high-yield dividend stock hand over fist. Through the dark clouds It's understandable why Pfizer stock has fallen so much. The drugmaker has faced some big challenges and has more on the way. Pfizer's revenue in 2023 fell 42% from the previous year. Sales for the company's top-selling product, COVID-19 vaccine Comirnaty, sank 70% year over year. Sales for Pfizer's COVID-19 pill Paxlovid plunged 93%. Ouch. Those COVID woes weren't Pfizer's only problem areas. Sales for six of the company's cancer drugs that generate $180 million or more annually fell by double-digit percentages. Revenue for Pfizer's best-selling cancer therapy, Ibrance, dropped 7% year over year in 2023. To make matters worse, the key U.S. patents for seven of Pfizer's products expire by 2027. All were blockbusters last year. So why am
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Global Retinoblastoma Treatment Market Size To Exceed USD 3.8 Billion By 2033 | CAGR of 4.28% [Yahoo! Finance]Yahoo! Finance
- Imre Continues its Brand AOR Evolution with Industry Veteran Christian Bauman as Chief Creative Officer [Yahoo! Finance]Yahoo! Finance
- LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead? [Yahoo! Finance]Yahoo! Finance
- Immersive Labs Unveils New ‘Dark Side of GenAI' Report about How People Trick Chatbots into Exposing Company Secrets [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/9/24 - Form S-8
- PFE's page on the SEC website